Chugai Venture Fund, LLC
chugaiventurefund.com Direct investor
Chugai Venture Fund is a subsidiary of Chugai Pharmaceutical Co., Ltd. that invests in early-stage life science companies, focusing on preclinical companies aligned with its parent's research areas. It provides funding and access to resources to support development of novel therapies.
Chugai Venture Fund, LLC is a corporate venture arm. It invests directly in companies, from seed to Series A, in oncology, immunology, CNS and ophthalmology. Its stated cheque size is mid-single million dollars with reserves for follow-on investments.
“CVF is a strategic corporate investment fund. We want to invest in promising management teams and great science that align with Chugai Pharmaceuticals’ R&D efforts.”
— Chugai Venture Fund, LLC, own website
- Layer
- Direct investor
- Sectors
- Oncology, Immunology, CNS, Ophthalmology, Metabolic Diseases, Rare Diseases, Platform technologies, Therapeutics
- Cheque size
- mid-single million dollars with reserves for follow-on investments
- How to reach it
- Its contact page on its own site
Team, as Chugai Venture Fund, LLC publishes it
- John Gustofson PRESIDENT
- Mike Dial, PhD MANAGING DIRECTOR
- Taku Fukuzawa, PhD PRINCIPAL
- Tatsushi Kodama, PhD ASSOCIATE
- Yoshikazu Ando, PhD, MBA ASSOCIATE
- Stefanie Feldmann OFFICE MANAGER
- Hayato Kurokawa FINANCE MANAGER
Names and roles exactly as listed on chugaiventurefund.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Chugai Venture Fund, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.chugaiventurefund.com/name, description, status, approach_url, stage_min
- https://www.chugaiventurefund.com/investment-scopeis_investor, layer, type, sectors, cheque_size, thesis_quote
- https://www.chugaiventurefund.com/teampeople
Record 20713 · added 2026-11-10 · link last verified 2026-11-10 · confidence high
Similar investors
- Astellas Venture ManagementCorporate venture · Seed – Series A · South San Francisco, United States
- Hikma VenturesCorporate venture · Series A – Growth · Amman, Jordan
- Johnson & Johnson Innovation – JJDCCorporate venture · Seed – Growth
- Sanofi VenturesCorporate venture · Seed – Series C+
- Novartis Venture FundCorporate venture · Seed – Growth · Basel, Switzerland
- 115KCorporate venture · Seed – Series B · Paris, France